Suggested for you
Explore suggested content tailored to your role within the CAR T-cell therapy journey
24-minute watch
EHA 2025
Timing is of the essence: The patient with MCL on a BTKi
Dr Martina Pennisi
21-minute watch
EHA 2025
Age is not a barrier: The older patient with comorbidities
Dr Mary Ann Anderson
20-minute watch
EHA 2025
Hope for the best, plan for the worst: The patient with DLBCL at high risk of relapse
Dr Lorenzo Falchi
8-minute watch
EBMT 2025
Charting a course in the CAR T age: SoC in 2L R/R DLBCL
Professor Fabio Ciceri
Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023
Keep up to date
Be the first to find out about Kite Cell Therapy Hub's upcoming content launches
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. In the United Kingdom, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.